SOCS1: Regulator of T Cells in Autoimmunity and Cancer.

[1]  R. Deng,et al.  Dendritic cells that highly express SOCS1 induce T-cell hypo-responsiveness and prolong islet allograft survival. , 2017, Cellular immunology.

[2]  G. Ferbeyre,et al.  Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer , 2017, BMC Cancer.

[3]  G. Ferbeyre,et al.  Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21CIP1/WAF1 in the liver , 2016, Oncogene.

[4]  D. Bobbala,et al.  The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions. , 2016, Cytokine.

[5]  F. Marincola,et al.  Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance , 2015, Journal for ImmunoTherapy of Cancer.

[6]  A. Ribas.  Adaptive Immune Resistance: How Cancer Protects from Immune Attack. , 2015, Cancer Discovery.

[7]  G. Freeman,et al.  Combination cancer immunotherapy and new immunomodulatory targets , 2015, Nature Reviews Drug Discovery.

[8]  Y. Doki,et al.  Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis , 2015, British Journal of Cancer.

[9]  G. Anderson,et al.  Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release , 2015, Immunity.

[10]  C. M. Ahmed,et al.  SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function , 2015, Front. Immunol..

[11]  J. Curtis,et al.  Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling , 2015, The Journal of experimental medicine.

[12]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[13]  M. Yeganeh,et al.  Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma , 2015, Oncogene.

[14]  T. Waldmann,et al.  miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines , 2014, Proceedings of the National Academy of Sciences.

[15]  Yong-nian Shen,et al.  Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro , 2014, Immunologic research.

[16]  N. Nicola,et al.  The molecular regulation of Janus kinase (JAK) activation. , 2014, The Biochemical journal.

[17]  A. Yoshimura,et al.  SOCS1 and Regulation of Regulatory T Cells Plasticity , 2014, Journal of immunology research.

[18]  Z. Berneman,et al.  Clinical use of dendritic cells for cancer therapy. , 2014, The Lancet. Oncology.

[19]  S. Hori.  Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells , 2014, Immunological reviews.

[20]  L. Rönnstrand,et al.  SOCS proteins in regulation of receptor tyrosine kinase signaling , 2014, Cellular and Molecular Life Sciences.

[21]  A. Sharma,et al.  The Role of Suppressors of Cytokine Signalling in Human Neoplasms , 2014, Molecular biology international.

[22]  N. Nicola,et al.  Inhibition of IL-6 family cytokines by SOCS3. , 2014, Seminars in immunology.

[23]  Hiroshi Takayanagi,et al.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis , 2013, Nature Medicine.

[24]  J. Bluestone,et al.  Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. , 2013, Immunity.

[25]  M. Ohh,et al.  SOCS-1 Mediates Ubiquitylation and Degradation of GM-CSF Receptor , 2013, PloS one.

[26]  Jason B. Williams,et al.  Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells , 2013, Science Translational Medicine.

[27]  D. Bobbala,et al.  SOCS1 prevents potentially skin-reactive cytotoxic T lymphocytes from gaining the ability to cause inflammatory lesions. , 2013, The Journal of investigative dermatology.

[28]  A. Yoshimura,et al.  SOCS, inflammation, and cancer , 2013, JAK-STAT.

[29]  C. Albanesi,et al.  Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses , 2013, European journal of immunology.

[30]  A. Yoshimura.  CIS: the late-blooming eldest son , 2013, Nature Immunology.

[31]  Shimon Sakaguchi,et al.  The plasticity and stability of regulatory T cells , 2013, Nature Reviews Immunology.

[32]  Erica G. Schmitt,et al.  Generation and Function of Induced Regulatory T Cells , 2013, Front. Immunol..

[33]  Lieping Chen,et al.  Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.

[34]  S. Sakaguchi,et al.  Development and maintenance of regulatory T cells. , 2013, Immunity.

[35]  A. Ward,et al.  SOCS proteins in development and disease. , 2013, American journal of clinical and experimental immunology.

[36]  Isabelle S. Lucet,et al.  SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition , 2013, Nature Structural &Molecular Biology.

[37]  C. Perreault,et al.  Differential effects of γc cytokines on postselection differentiation of CD8 thymocytes. , 2013, Blood.

[38]  H. Hirano,et al.  Identification of miR-30d as a novel prognostic maker of prostate cancer , 2012, Oncotarget.

[39]  Huanhuan Li,et al.  MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1 , 2012, PloS one.

[40]  Y. Doki,et al.  Antiproliferative effect of SOCS‐1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells , 2012, International journal of cancer.

[41]  N. Bottini,et al.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity , 2012, Immunology.

[42]  J. Banchereau,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[43]  T. Speed,et al.  The N‐terminal domains of SOCS proteins: A conserved region in the disordered N‐termini of SOCS4 and 5 , 2012, Proteins.

[44]  R. Norton,et al.  Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. , 2012, Immunity.

[45]  A. Yoshimura,et al.  JAK's SOCS: a mechanism of inhibition. , 2012, Immunity.

[46]  S. Akira,et al.  Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells , 2012, Nature Immunology.

[47]  C. Hsieh,et al.  Selection of regulatory T cells in the thymus , 2012, Nature Reviews Immunology.

[48]  C. Qian,et al.  Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma , 2012, Gene Therapy.

[49]  T. Kamura,et al.  The Role of Elongin BC-Containing Ubiquitin Ligases , 2011, Front. Oncol..

[50]  R. Morita,et al.  SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-γ and IL-17A production , 2011, The Journal of experimental medicine.

[51]  H. Weiner,et al.  Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Immunology.

[52]  Mahavir Singh,et al.  Silencing Suppressor of Cytokine Signaling-1 (SOCS1) in Macrophages Improves Mycobacterium tuberculosis Control in an Interferon-γ (IFN-γ)-dependent Manner* , 2011, The Journal of Biological Chemistry.

[53]  P. Ohashi,et al.  Exposure to IL-15 and IL-21 Enables Autoreactive CD8 T Cells To Respond to Weak Antigens and Cause Disease in a Mouse Model of Autoimmune Diabetes , 2011, The Journal of Immunology.

[54]  G. Punkosdy,et al.  IL-2 Controls the Stability of Foxp3 Expression in TGF-β–Induced Foxp3+ T Cells In Vivo , 2011, The Journal of Immunology.

[55]  L. Harrington,et al.  Cytokines and the inception of CD8 T cell responses. , 2011, Trends in immunology.

[56]  Lilian W. Waiboci,et al.  The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis , 2011, Journal of Neuroimmunology.

[57]  A. Dalpke,et al.  Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  B. Baban,et al.  Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. , 2010, Immunity.

[59]  Ryan M. O’Connell,et al.  MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. , 2010, Immunity.

[60]  David Baltimore,et al.  Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses , 2010, Cell.

[61]  S. Ramanathan,et al.  Increased generation of CD8 single positive cells in SOCS1-deficient thymus does not proportionately increase their export. , 2010, Immunology letters.

[62]  G. Ferbeyre,et al.  Regulation of Cytokine-Driven Functional Differentiation of CD8 T Cells by Suppressor of Cytokine Signaling 1 Controls Autoimmunity and Preserves Their Proliferative Capacity toward Foreign Antigens , 2010, The Journal of Immunology.

[63]  J. Curtsinger,et al.  Inflammatory cytokines as a third signal for T cell activation. , 2010, Current opinion in immunology.

[64]  Shuai Jiang,et al.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.

[65]  M. Kubo,et al.  Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells , 2010, Nature Immunology.

[66]  W. Heath,et al.  Dendritic cell subsets in primary and secondary T cell responses at body surfaces , 2009, Nature Immunology.

[67]  N. Restifo,et al.  Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. , 2009, Trends in immunology.

[68]  T. Kay,et al.  SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus , 2009, Immunology and cell biology.

[69]  J. Hawiger,et al.  Intracellular Delivery of a Cell-Penetrating SOCS1 that Targets IFN-γ Signaling , 2009, Science Signaling.

[70]  A. Sharpe,et al.  SnapShot: B7/CD28 Costimulation , 2009, Cell.

[71]  W. Paul,et al.  IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation , 2009, Proceedings of the National Academy of Sciences.

[72]  R. Norton,et al.  The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. , 2009, Journal of molecular biology.

[73]  B. Malissen,et al.  Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity , 2009, Proceedings of the National Academy of Sciences.

[74]  P. Steeg,et al.  Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. , 2008, Cancer research.

[75]  K. Heeg,et al.  Identification of a nuclear localization signal in suppressor of cytokine signaling 1 , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  C. Croce,et al.  MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis , 2008, Proceedings of the National Academy of Sciences.

[77]  Oreste Acuto,et al.  Tailoring T-cell receptor signals by proximal negative feedback mechanisms , 2008, Nature Reviews Immunology.

[78]  Alexandre Cloutier,et al.  IL-6, in Synergy with IL-7 or IL-15, Stimulates TCR-Independent Proliferation and Functional Differentiation of CD8+ T Lymphocytes1 , 2008, The Journal of Immunology.

[79]  N. Hayashi,et al.  Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. , 2008, International immunology.

[80]  A. Yoshimura,et al.  Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads1 , 2008, The Journal of Immunology.

[81]  I. Macara,et al.  Septins Regulate Actin Organization and Cell-Cycle Arrest through Nuclear Accumulation of NCK Mediated by SOCS7 , 2007, Cell.

[82]  W. Alexander,et al.  The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. , 2007, Blood.

[83]  J. Leignadier,et al.  IL‐21 promotes T lymphocyte survival by activating the phosphatidylinositol‐3 kinase signaling cascade , 2007, Journal of leukocyte biology.

[84]  Sungpil Yoon,et al.  The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels. , 2007, Biochemical and biophysical research communications.

[85]  Yong‐jun Liu,et al.  Development of dendritic-cell lineages. , 2007, Immunity.

[86]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[87]  J. Curtsinger,et al.  Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. , 2007, Seminars in immunology.

[88]  S. Ramanathan,et al.  Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes. , 2007, Cellular signalling.

[89]  X. Mao,et al.  COMMD1 promotes the ubiquitination of NF‐κB subunits through a cullin‐containing ubiquitin ligase , 2007, The EMBO journal.

[90]  K. Heeg,et al.  Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. , 2006, Blood.

[91]  J. Harty,et al.  Inflaming the CD8+ T cell response. , 2006, Immunity.

[92]  Seiya Kato,et al.  IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice , 2006, The Journal of experimental medicine.

[93]  Terence P. Speed,et al.  The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling* , 2006, Journal of Biological Chemistry.

[94]  R. Rottapel,et al.  Suppressor of Cytokine Signaling 1 Stringently Regulates Distinct Functions of IL-7 and IL-15 In Vivo during T Lymphocyte Development and Homeostasis1 , 2006, The Journal of Immunology.

[95]  H. Ogata,et al.  Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved. , 2006, Gastroenterology.

[96]  A. Singer,et al.  Cytokine signal transduction is suppressed in preselection double-positive thymocytes and restored by positive selection , 2006, The Journal of experimental medicine.

[97]  Paul J Hertzog,et al.  Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation , 2006, Nature Immunology.

[98]  Xiao-tong Song,et al.  SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. , 2005, The Journal of clinical investigation.

[99]  W. Alexander,et al.  SOCS-1 regulates IL-15–driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential , 2005, The Journal of experimental medicine.

[100]  J. Curtsinger,et al.  Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis1 , 2005, The Journal of Immunology.

[101]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[102]  W. Alexander,et al.  Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. , 2005, Blood.

[103]  M. Kubo,et al.  The role of suppressor of cytokine signaling 1 as a negative regulator for aberrant expansion of CD8alpha+ dendritic cell subset. , 2005, International immunology.

[104]  T. Waldmann,et al.  Survival adjustment of mature dendritic cells by IL-15. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[105]  S. Hedrick,et al.  Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells , 2005, Nature Immunology.

[106]  J. Curtsinger,et al.  Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1 , 2005, The Journal of Immunology.

[107]  H. Aburatani,et al.  Induction of Hyper Th1 Cell-Type Immune Responses by Dendritic Cells Lacking the Suppressor of Cytokine Signaling-1 Gene1 , 2005, The Journal of Immunology.

[108]  L. Flowers,et al.  A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells , 2005, Oncogene.

[109]  J. Berzofsky,et al.  Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function , 2005, The Journal of experimental medicine.

[110]  R. Rottapel,et al.  Regulation of the immune system by SOCS family adaptor proteins. , 2004, Seminars in immunology.

[111]  Lei Shen,et al.  Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity , 2004, Nature Biotechnology.

[112]  M. Baniyash.  TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response , 2004, Nature Reviews Immunology.

[113]  J. Vandenhaute,et al.  The suppressor of cytokine signaling (SOCS)-7 interacts with the actin cytoskeleton through vinexin. , 2004, Experimental cell research.

[114]  Takafumi Yoshida,et al.  SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis , 2004, The Journal of experimental medicine.

[115]  S. Ebong,et al.  Dendritic Cell Maturation Requires STAT1 and Is under Feedback Regulation by Suppressors of Cytokine Signaling , 2004, The Journal of Immunology.

[116]  Y. Shima,et al.  Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. , 2004, International immunology.

[117]  T. Naka,et al.  Regulation of cytokine signaling by SOCS family molecules. , 2003, Trends in immunology.

[118]  José La Rose,et al.  Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes. , 2003, Blood.

[119]  Oreste Acuto,et al.  CD28-mediated co-stimulation: a quantitative support for TCR signalling , 2003, Nature Reviews Immunology.

[120]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[121]  K. Vuori,et al.  Negative regulation of FAK signaling by SOCS proteins , 2003, The EMBO journal.

[122]  José La Rose,et al.  Suppressor of Cytokine Signaling 1 Regulates IL-15 Receptor Signaling in CD8+CD44high Memory T Lymphocytes 1 , 2003, The Journal of Immunology.

[123]  M. Kubo,et al.  Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. , 2003, Immunity.

[124]  W. Alexander,et al.  Suppressor of Cytokine Signaling-1 Regulates Signaling in Response to Interleukin-2 and Other γc-dependent Cytokines in Peripheral T Cells* , 2003, Journal of Biological Chemistry.

[125]  Donald Metcalf,et al.  SOCS3 negatively regulates IL-6 signaling in vivo , 2003, Nature Immunology.

[126]  S. Akira,et al.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages , 2003, Nature Immunology.

[127]  J. Curtsinger,et al.  Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells , 2003, The Journal of experimental medicine.

[128]  E. Stanley,et al.  Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. , 2003, Immunity.

[129]  R. Schwartz.  T cell anergy. , 2003, Annual review of immunology.

[130]  W. Alexander,et al.  Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. , 2003, The Journal of clinical investigation.

[131]  W. Alexander,et al.  Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis1 , 2003, The Journal of Immunology.

[132]  M. Naramura,et al.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation , 2002, Nature Immunology.

[133]  Kenji Nakanishi,et al.  SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.

[134]  M. Kubo,et al.  SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. , 2002, Immunity.

[135]  M. Gassmann,et al.  Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. , 2002, Immunity.

[136]  Stephen C. Jameson,et al.  Maintaining the norm: T-cell homeostasis , 2002, Nature Reviews Immunology.

[137]  Warren S. Alexander,et al.  Suppressors of cytokine signalling (SOCS) in the immune system , 2002, Nature Reviews Immunology.

[138]  Philip D. Hodgkin,et al.  Activation rules: the two-signal theories of immune activation , 2002, Nature Reviews Immunology.

[139]  W. Alexander,et al.  The SOCS box: a tale of destruction and degradation. , 2002, Trends in biochemical sciences.

[140]  W. Alexander,et al.  Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1) , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[141]  W. Alexander,et al.  The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[142]  J. Bluestone,et al.  Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. , 2001, The Journal of clinical investigation.

[143]  F. Belardelli,et al.  IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1 , 2001, The Journal of Immunology.

[144]  C. Elly,et al.  Cbl Promotes Ubiquitination of the T Cell Receptor ζ through an Adaptor Function of Zap-70* , 2001, The Journal of Biological Chemistry.

[145]  Guy Mouchiroud,et al.  Suppressor of Cytokine Signaling 1 Interacts with the Macrophage Colony-stimulating Factor Receptor and Negatively Regulates Its Proliferation Signal* , 2001, The Journal of Biological Chemistry.

[146]  J. Herman,et al.  SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity , 2001, Nature Genetics.

[147]  R. Rottapel,et al.  Overexpression of suppressor of cytokine signaling-1 impairs pre-T-cell receptor-induced proliferation but not differentiation of immature thymocytes. , 2001, Blood.

[148]  R. Ahmed,et al.  Cutting Edge: Naive T Cells Masquerading as Memory Cells , 2000, The Journal of Immunology.

[149]  R. Nakagawa,et al.  Defective Thymocyte Development and Perturbed Homeostasis of T cells in STAT-Induced STAT Inhibitor-1/Suppressors of Cytokine Signaling-1 Transgenic Mice1 , 2000, The Journal of Immunology.

[150]  A Sasaki,et al.  Negative regulation of cytokine signaling pathways. , 2000, Annual review of immunology.

[151]  A. Yoshimura,et al.  SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.

[152]  Paul J Hertzog,et al.  SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.

[153]  J. Johnston,et al.  Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[154]  A. Yoshimura,et al.  The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop , 1999, The EMBO journal.

[155]  K. Okkenhaug,et al.  Socs1 binds to multiple signalling proteins and suppresses Steel factor‐dependent proliferation , 1999, The EMBO journal.

[156]  W. Alexander,et al.  Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction , 1999, The EMBO journal.

[157]  Y. Uchiyama,et al.  Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[158]  A. Elefanty,et al.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[159]  U. Ikeda,et al.  SOCS-1/JAB/SSI-1 Can Bind to and Suppress Tec Protein-tyrosine Kinase* , 1997, The Journal of Biological Chemistry.

[160]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[161]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[162]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[163]  N. Copeland,et al.  A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.

[164]  Ziqiang Zhu,et al.  Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[165]  W. Leonard,et al.  JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. , 2001, Blood.

[166]  A. Yoshimura,et al.  SOCS-1 can suppress CD3zeta- and Syk-mediated NF-AT activation in a non-lymphoid cell line. , 2000, FEBS letters.